What Is PHA (Polyhydroxyalkanoates)? Bioplastic Guide for Medical Supplies

August 1, 2026

PHA (polyhydroxyalkanoates) is a family of biopolymers produced by microbial fermentation, gaining ground in sustainable medical supplies. For procurement teams weighing biodegradable alternatives to conventional plastics, what PHA bioplastic is, and where it stands commercially, matters more than marketing claims. This guide covers the science, the market, and the procurement picture.

What Are Polyhydroxyalkanoates (PHA)?

PHA (polyhydroxyalkanoates) are polyesters synthesized inside bacterial cells as carbon and energy storage compounds. Fed renewable feedstocks such as plant sugars or vegetable oils under nutrient-limited conditions, microorganisms accumulate polymer granules inside their cells. The polymer is then extracted and processed into resins, films, fibers, and molded parts.

PHA bioplastic is not a single material but a family. The most common member is polyhydroxybutyrate (PHB), with copolymers such as PHBV (with valerate) and PHBHHx (with hydroxyhexanoate) offering modified flexibility and degradation profiles. Repeat units can be tuned, so mechanical properties suit applications from rigid packaging to elastic films. A 2021 review in Polymers (MDPI) highlighted the biomedical potential of these copolymers and their adjustable degradation rates.

How PHA Compares to PLA

Polylactic acid (PLA) is the more established bioplastic, and CliniEco's current product range is built on it. The two materials share a renewable origin but differ in end-of-life behavior. PLA typically requires industrial composting, with sustained temperatures around 58°C, to meet standards such as ASTM D6400 and EN 13432. PHA bioplastic, by contrast, can undergo home composting and degrades in soil and marine environments, where many PLA grades remain stable.

PHA and PLA biodegradable medical waste bags from CliniEco

That distinction matters for facilities without access to industrial composting infrastructure. PHA's advantages include home-compostability, marine biodegradation, and greater flexibility, which suits films and nonwovens. Its drawbacks are equally real: higher cost, lower global production volume, and a shorter track record in medical-grade applications. None of this diminishes PLA, which remains a reliable, cost-effective workhorse; the two materials are complementary.

PHA in Medical Supplies

Research interest in PHA bioplastic for healthcare has grown steadily. Studies published in journals such as Bioresource Technology and in MDPI Polymers reviews have examined PHA-based wound dressings, resorbable sutures, and drug delivery systems, where slow, tunable degradation is valuable. PHA films and coatings are also under evaluation for pharmaceutical packaging.

Biodegradable isolation gown made from plant-based polymers

Precision about maturity is needed. Much of this work remains at the research and pilot stage, and commercially marketed PHA medical devices are still limited compared with PLA- or conventional-polymer products. Facilities should treat PHA as an emerging option with strong scientific backing, not a commoditized supply category.

Key PHA Producers

Commercial PHA production is concentrated among a handful of producers. Danimer Scientific markets its Nodax copolymers for packaging and coatings; Kaneka produces PHA grades for rigid and flexible applications; CJ CheilJedang operates PHA production through its bio-business division; and Newlight Technologies converts greenhouse gases into PHA resins.

Market context matters for procurement planning. According to European Bioplastics and market analyses such as Grand View Research's, global PHA production capacity sits at roughly 100 kilotonnes per year, a fraction of PLA capacity, estimated at 400–500 kilotonnes. That gap explains the price premium and limited supplier options.

Is PHA Right for Your Facility?

From a procurement standpoint, the honest answer is: it depends on your priorities. PHA bioplastic fits facilities that need genuine home-compostable or marine-biodegradable performance and are willing to pay a premium for a differentiated sustainability story. Pilot programs are a sensible entry point, letting a facility validate performance and staff handling before committing to volume.

For most routine clinical waste and single-use applications, PLA remains the practical choice, and it is the basis of CliniEco's current range of biodegradable waste bags, isolation gowns, and bed sheets. CliniEco's dual-track sustainable supply approach keeps PLA products available for volume needs while tracking PHA developments so buyers can adopt it as commercial supply matures. For a closer comparison, see our PHA vs PLA guide.

PHA FAQ

Is PHA biodegradable at home?

Yes. Unlike PLA, which typically requires industrial composting conditions to meet ASTM D6400, PHA bioplastic can degrade in home compost systems, soil, and marine environments. Actual degradation rates depend on the copolymer, thickness, and environmental conditions.

How long does PHA take to degrade?

There is no single answer. Laboratory and field studies report timelines from weeks to more than a year depending on polymer composition and environment. In home compost, thin PHA films may break down within a few months; thicker molded parts take longer. Always validate claims against the supplier's test data.

Is PHA safe for medical use?

PHA bioplastic has demonstrated biocompatibility in numerous studies, and its degradation products are natural metabolites found in the human body, which is why resorbable sutures and drug delivery systems are active research areas. However, most PHA medical applications remain in development; verify that any marketed product carries the required regulatory approvals.